PharmaLex is now part of AmerisourceBergen, a leading global healthcare company with a foundation in pharmaceutical distribution.
Together, PharmaLex and AmerisourceBergen offer end-to-end product commercialization, including global market access strategy and execution, to drive patients’ healthier futures wherever they are in the world.
PharmaLex complements AmerisourceBergen’s existing suite of services by continuing to service the pharma, biotech and medtech industries, guiding clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
Together, PharmaLex and AmerisourceBergen offer end-to-end product commercialization, including global market access strategy and execution, to drive patients’ healthier futures wherever they are in the world.
PharmaLex complements AmerisourceBergen’s existing suite of services by continuing to service the pharma, biotech and medtech industries, guiding clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
